Biomea Fusion : Presentation for Conference Call to Discuss Clinical Data From the First Two Cohorts of BMF-219 in Patients With Type 2 Diabetes

COVALENT-111: Phase II


First Data Readout of Initial Healthy Volunteer and Type 2 Diabetes Mellitus Cohorts


March 28, 2023


... | March 28, 2023

Related Keywords

Juan Frias ,Steve Morris ,Thomas Butler ,Rohit Kulkarni ,Exchange Commission ,Professor Of Medicine Harvard Medical School ,Joslin Diabetes Center ,Biomea Fusion Inc ,While The Company ,Board Co ,Principal Investigator Of Velocity Clinical Research ,Beta Cell Health ,Data Readout ,Initial Healthy Volunteer ,Biomea Fusion ,Operating Officer ,Principal Investigator ,Velocity Clinical Research ,Scientific Advisory Board Member ,Harvard Medical School ,Faculty Member ,Advisory Board Member ,Medical Officer ,Executive Officer ,Beta Cell ,Beta Cell Loss ,Diabetes Therapies ,Beta Cell Mass ,Glucose Tolerance ,Impaired Glucose Tolerance ,Insulin Resistance ,Beta Cell Workload ,Beta Cell Failure ,Nc Stock Exchange ,News ,Information ,Press Release ,Hase ,First ,Data ,Readout ,F ,Nitial ,Healthy ,Volunteer ,End ,Type , ,Diabetes ,Mellitus ,Arch Bmea Us09077a1060 ,